The previous study combined thrombocytopenia and kidney dysfunction in the definition of severe disease, whereas the current study only demonstrated an association of decreased IP-10 levels in patients solely grouped based on severe kidney dysfunction. This evidence concerns the gene CXCL10 and Thrombocytopenia.